Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1347 of 6351
-
Belly fat melting shot? phase 3 trial begins.
Disease control Not yet recruitingA phase 3, randomized, double-blinded, placebo-controlled study to evaluate the efficacy, safety, and tolerability of CBL-514 injection for reducing abdominal subcutaneous fat.
Phase 3 • Sponsor: Caliway Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
SAMe supplement may shield liver from chemo harm
Prevention Not yet recruitingThis is an open-label, phase II study that may provide evidence that taking S-adenosylmethionine (SAMe) supplementation prevents oxaliplatin, a type of chemotherapy drug, associated liver toxicity in patients with resectable colorectal liver metastases. Resectable means that it i…
Phase 2 • Sponsor: Cedars-Sinai Medical Center • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Brain zaps vs. brain zaps: which one helps veterans kick the habit?
Disease control Recruiting nowCigarette smoking is a significant public health concern for Veterans. Encouraging smoking cessation continues to be a top priority for the Veterans' Administration as Veterans who use tobacco experience negative health effects, including cancer, heart disease, and mental disorde…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Triple threat: new combo therapy aims to tackle rare lung disease
Disease control Not yet recruitingThe study aims to see how 24 weeks of triple therapy-an endothelin receptor antagonist (ERA), a phosphodiesterase-5 inhibitor (PDE5i), and sotatercept-affects pulmonary vascular resistance (PVR) in patients with newly diagnosed pulmonary arterial hypertension (PAH). SIRIUS is a 2…
Phase 2 • Sponsor: Philipps University Marburg • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New dressing uses nitric oxide to fight diabetic foot ulcers
Disease control Not yet recruitingReal world evidence study on the performance and safety of a nitric oxide generating dressing on the treatment of diabetic foot ulcers
Sponsor: ConvaTec Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New pill could ease rare lung disease
Disease control Not yet recruitingA Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Finding Trial to Evaluate the Efficacy and Safety of Orally Administered NS-863 in Participants with Pulmonary Arterial Hypertension (PAH)
Phase 2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Blood test may replace needle biopsies for prostate cancer watch
Knowledge-focused Not yet recruitingThe CHAS3 trial studies whether the Stockholm3 blood test can reliably detect if prostate cancer becomes more aggressive in men who are being carefully monitored instead of treated right away (active surveillance). The goal is to see if this test can help doctors safely follow pa…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Can a diuretic shield kidneys from contrast dye in heart failure?
Disease control Recruiting nowThe K-PROSE study is a randomized clinical investigation evaluating strategies to prevent contrast-induced acute kidney injury (CI-AKI) in patients hospitalized with acute heart failure and moderate renal dysfunction (eGFR 30-75 mL/min/1.73 m²). Patients requiring contrast-enhanc…
Sponsor: Jin Joo Park • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Can we predict sudden cardiac death after a heart attack? new study aims to find out
Knowledge-focused Not yet recruitingAlthough advances in treatment and patient management have considerably improved post-infarction prognosis, the risk of sudden cardiac death remains a major concern. Sudden cardiac death (SCD) is defined as an unexpected death occurring within one hour of the onset of symptoms, o…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New procedure aims to cut repeat brain bleed surgeries
Disease control Not yet recruitingChronic subdural hematoma (cSDH) is a common condition, particularly in older adults, that can substantially impair patients' quality of life, functional independence, and neurological well-being. Blood accumulates in the subdural space and persists due to the formation of a high…
Sponsor: Charite University, Berlin, Germany • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New drug targets tough cancers with KRas G12V mutation
Disease control Not yet recruitingPhase 1, open-label, multicenter study to evaluate the safety, tolerability, PK, PD, and preliminary clinical activity of CLSP 5282 when administered to HLA A\*03:01-positive adult patients with advanced solid tumors that harbor the KRas G12V mutation.
Phase 1 • Sponsor: Clasp Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for bile duct cancer: drug duo targets tough tumors
Disease control Not yet recruitingBiliary tract carcinoma (BTC), including cholangiocarcinoma and gallbladder cancer, is a highly aggressive digestive system malignancy with limited treatment options after failure of first-line standard chemotherapy. This open-label, single-arm, Phase II exploratory study aims t…
Phase 2 • Sponsor: HuiKai Li • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Minced cartilage implant may outperform standard microfracture for hip damage
Disease control Not yet recruitingA femoroacetabular impingement (FAI) is an abnormal contact between pelvis and the neck of femur. It occurs particularly when patient bends his hip and causes damage to the cartilage. In the long term, FAI can lead to the development of osteoarthritis (cartilage destruction) and …
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Major trial tests if early aspirin stop is safe for Moms-to-Be
Prevention Not yet recruitingPregnant women at higher risk for preeclampsia (PE) are currently recommended to take low-dose aspirin (acetylsalicylic acid, ASA) daily from the first trimester until 36 weeks of gestation. High-risk women are identified through a multiparametric first-trimester screening that c…
Phase 3 • Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
New hope for HIV patients who failed long-acting shots: switching to a daily pill
Disease control Not yet recruitingThis study is a pilot, multi-center, observational retrospective-prospective study, with two different Parts, as follows: 1. Part 1(retrospective and prospective part): to evaluate efficacy and safety of switching to BIC/FTC/TAF in People living with HIV (PWH) who previously fai…
Sponsor: Cristina Mussini • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Stroke recovery goes home: robot hand trainer could boost therapy without a therapist
Disease control Not yet recruitingThe ReHandyBot (RHB) is a robot for hand rehabilitation after stroke. The aims of this study are to investigate (i) the generalizability of unsupervised therapy with the ReHandyBot within patients' home after discharge from a clinic, (ii) compliance, as measured by the amount of …
Sponsor: Swiss Federal Institute of Technology • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Zapping nerves to ease Post-Mastectomy pain: which target works best?
Symptom relief Not yet recruitingThe aim of this study is to compare the effectiveness of super-voltage pulsed radiofrequency of stellate ganglion and super-voltage pulsed radiofrequency of T2-T3 sympathetic ganglia in the treatment of postmastectomy pain syndrome.
Sponsor: National Cancer Institute, Egypt • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Could a 5-Day brain stimulation blitz ease depression in PTSD?
Symptom relief Not yet recruitingThe goal of this pilot clinical trial is to learn if a faster brain stimulation schedule is practical, safe, tolerable, and acceptable. This study looks at accelerated intermittent theta burst stimulation, or accelerated iTBS. This is a non-invasive type of magnetic brain stimula…
Sponsor: Lawson Research Institute of St. Joseph's • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Eye injection shows promise for rare Fungal-Related blindness
Disease control Recruiting nowThis study will evaluate the safety and effects, good or bad of faricimab (Vabysmo®), a drug that is approved by the U.S. Food and Drug Administration (FDA) for other retinal conditions, but its use is considered investigational when used specifically for choroidal neovasculariza…
Phase 4 • Sponsor: Cincinnati Eye Institute, Southwest Ohio • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
AI camera system could replace subjective ratings for Drug-Induced movement disorders
Diagnosis Not yet recruitingThis prospective, single-center observational study aims to develop and validate a computer-assisted tool for the objective quantitative assessment of extrapyramidal symptoms (EPS). The study will enroll 180 participants, including 90 healthy controls and 90 participants with cl…
Sponsor: Shanghai Mental Health Center • Aim: Diagnosis
Last updated Jul 23, 2026 00:00 UTC